Drug repositioning for esophageal squamous cell carcinoma

Drug repositioning for esophageal squamous cell carcinoma

Esophageal cancer (EC) remains a significant challenge globally, having the 8th highest incidence and 6th highest mortality worldwide. Esophageal squamous cell carcinoma (ESCC) is the most common form of EC in Asia. Crucially, more than 90% of EC cases in China are ESCC. The high mortality rate of E...

Full description

Bibliographic Details
Main Authors: Adam N. Bennett, Rui Xuan Huang, Qian He, Nikki P. Lee, Wing-Kin Sung, Kei Hang Katie Chan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Genetics
Subjects:
drug repositioning
drug repurposing
esophageal squamous cell carcinoma
ESCC treatment
cancer biology
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.991842/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.991842/full

Similar Items